| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.2833 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.2833 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.2833 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.3776 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.3998 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4295 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4409 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4605 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4746 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4942 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.4962 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5089 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5348 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5386 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5486 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5550 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5646 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5681 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5757 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.5988 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6033 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6056 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6200 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6209 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6297 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.6688 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7025 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7410 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7446 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7485 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7502 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7845 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.7951 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8027 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8037 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8080 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8427 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8431 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8438 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8575 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8654 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.8790 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9131 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9315 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9460 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9665 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9744 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9815 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9869 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9872 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 0.9880 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.0000 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.0439 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.0739 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.0851 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.0882 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.1404 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.1473 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.1559 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.1987 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.2394 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3198 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3829 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3844 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3844 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3856 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3896 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.3934 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.4011 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.4121 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.4386 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.4822 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5222 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5284 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5425 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5430 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5643 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5815 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5980 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.5992 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.6379 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.6908 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 1.8960 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.0231 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.1125 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.1761 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.2280 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.2356 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.5372 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.5698 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.6829 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.7245 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.9020 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 2.9513 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 3.1101 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 3.2195 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 3.5315 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 3.6378 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 3.7993 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 4.1704 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 4-hydroxyphenylacetate | 6.3672 | Peak area | Diabetic non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|